ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 10th April, 2024 received from our RTA.10-04-2024
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation dated 10th April, 2024 received from our RTA.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached the certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached herewith the Postal Ballot Notice.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the Copy of Newspaper Publication dated 8th April, 2024.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30
Kindly find attached herewith the Intimation under Regulation 30 of SEBI LODR, Regulations 2015.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliance Certificate For The Financial Year Ended 31St March, 2024
Please find attached herewith the Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR Regulations, 2015 for the Financial Year ended March 31, 2024.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Alembic Global Holding SA, WOS of Alembic Pharmaceuticals Limited has subscribed in New entity TicTwo Therapeutics Inc.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Company has received two orders from Office of Assistant Commissioner of Central GST and Central Excise, Vadodara, imposing penalty.Alembic Pharma Gets Tentative USFDA Nod For Breast Cancer Drug
Alembic Pharma receives tentative USFDA approval for generic Ribociclib tablets, used in the treatment of breast cancer.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached herewith the intimation received from our RTA dated 1st April, 2024.